Time-varying compartmental models capture hours-scale variation in the elimination kinetics of vancomycin in rats

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Matthew H. McDonough, Julian Gerson, Tod Kippin, Wendy Meiring, Kevin W. Plaxco
{"title":"Time-varying compartmental models capture hours-scale variation in the elimination kinetics of vancomycin in rats","authors":"Matthew H. McDonough,&nbsp;Julian Gerson,&nbsp;Tod Kippin,&nbsp;Wendy Meiring,&nbsp;Kevin W. Plaxco","doi":"10.1111/bph.70020","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background and Purpose</h3>\n \n <p>Pharmacokinetics have traditionally been assessed using concentration measurements with relatively low temporal resolution, such as from blood draws, leading to pharmacokinetic profiles estimated from sparse data, often averaged across subjects. Recent advances in in vivo sensors, however, now enable the collection of hundreds of observations over a few hours in individual subjects. Previous analyses of such data for the antibiotic tobramycin identified significant (several-fold), hours-scale changes in the efficiency with which this renally cleared drug is eliminated in anaesthetised rats. Here, we apply similar analyses to study the pharmacokinetics of another renally cleared drug, the antibiotic vancomycin.</p>\n </section>\n \n <section>\n \n <h3> Experimental Approach</h3>\n \n <p>We estimate vancomycin pharmacokinetic profiles using previously collected time-dense plasma concentration measurements within six anaesthetised rats. Specifically, we fit standard one- and two-compartment models, as well as time-varying one-compartment models (in which the proportionality relating concentration to elimination rate is time-varying), to these data to investigate if the time-varying models are statistically preferred for describing individual-level vancomycin pharmacokinetics, over standard one- and two-compartment models.</p>\n </section>\n \n <section>\n \n <h3> Key Results</h3>\n \n <p>One-compartment models incorporating time-varying elimination proportionalities are statistically preferred over standard one- and two-compartment models for five of our six vancomycin time courses. When the initial impact of the distribution phase is removed from these data, a reciprocally time-varying one-compartment model is preferred over the standard-one compartment model in four of five considered datasets.</p>\n </section>\n \n <section>\n \n <h3> Conclusion and Implications</h3>\n \n <p>These results provide further animal-model evidence that the pharmacokinetics of renally cleared drugs can vary significantly over timescales as short as a few hours.</p>\n </section>\n </div>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":"182 13","pages":"2986-2996"},"PeriodicalIF":6.8000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bph.70020","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose

Pharmacokinetics have traditionally been assessed using concentration measurements with relatively low temporal resolution, such as from blood draws, leading to pharmacokinetic profiles estimated from sparse data, often averaged across subjects. Recent advances in in vivo sensors, however, now enable the collection of hundreds of observations over a few hours in individual subjects. Previous analyses of such data for the antibiotic tobramycin identified significant (several-fold), hours-scale changes in the efficiency with which this renally cleared drug is eliminated in anaesthetised rats. Here, we apply similar analyses to study the pharmacokinetics of another renally cleared drug, the antibiotic vancomycin.

Experimental Approach

We estimate vancomycin pharmacokinetic profiles using previously collected time-dense plasma concentration measurements within six anaesthetised rats. Specifically, we fit standard one- and two-compartment models, as well as time-varying one-compartment models (in which the proportionality relating concentration to elimination rate is time-varying), to these data to investigate if the time-varying models are statistically preferred for describing individual-level vancomycin pharmacokinetics, over standard one- and two-compartment models.

Key Results

One-compartment models incorporating time-varying elimination proportionalities are statistically preferred over standard one- and two-compartment models for five of our six vancomycin time courses. When the initial impact of the distribution phase is removed from these data, a reciprocally time-varying one-compartment model is preferred over the standard-one compartment model in four of five considered datasets.

Conclusion and Implications

These results provide further animal-model evidence that the pharmacokinetics of renally cleared drugs can vary significantly over timescales as short as a few hours.

时变室室模型捕捉万古霉素在大鼠体内消除动力学的小时尺度变化。
背景和目的:药代动力学传统上是通过相对低时间分辨率的浓度测量来评估的,例如通过抽血,导致药代动力学概况从稀疏数据估计,通常在受试者之间平均。然而,体内传感器的最新进展现在可以在几个小时内对单个受试者进行数百次观察。先前对抗生素妥布霉素这类数据的分析发现,在麻醉大鼠体内,这种肾脏清除药物的效率发生了显著的(几倍的)小时级变化。在这里,我们应用类似的分析来研究另一种肾脏清除药物——抗生素万古霉素的药代动力学。实验方法:我们使用先前收集的六只麻醉大鼠的时间密度血浆浓度测量来估计万古霉素的药代动力学特征。具体来说,我们对这些数据拟合标准的一室和两室模型,以及时变的一室模型(其中浓度与消除率的比例是时变的),以研究时变模型是否在统计上优于标准的一室和两室模型来描述个体水平的万古霉素药代动力学。关键结果:在我们的6个万古霉素疗程中,有5个包含时变消除比例的单室模型在统计学上优于标准的一室和二室模型。当从这些数据中去除分布阶段的初始影响时,在五个考虑的数据集中的四个中,一个往复时变的一室模型优于标准一室模型。结论和意义:这些结果提供了进一步的动物模型证据,表明肾脏清除药物的药代动力学可以在短至几小时的时间尺度上发生显着变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信